世界のIVD感染症市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global IVD Infectious Diseases Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4399
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、116ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、IVD感染症の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（免疫化学、分子診断）、用途別市場規模（臨床検査室、診断センター）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・IVD感染症の市場動向
・企業の競争状況、市場シェア
・IVD感染症の種類別市場規模と予測2016-2027（免疫化学、分子診断）
・IVD感染症の用途別市場規模と予測2016-2027（臨床検査室、診断センター）
・IVD感染症の北米市場規模2016-2027（アメリカ、カナダ）
・IVD感染症の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・IVD感染症のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・IVD感染症の中南米市場規模2016-2027（メキシコ、ブラジル）
・IVD感染症の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（BD、BioMerieux、Abbott、Quidel、Gen-Probe、Abbott、Danaher、Sysmex、Orasure、Hologic、Cepheid、Qiagen、Roche Diagnostics、Siemens Healthcare、Bio-Rad Laboratories）
・結論

In Vitro Diagnostics (IVDs) are medical devices and accessories used to perform tests on samples, (e.g., blood, urine and tissue that has been taken from the human body) in order to help detect infection, Diagnose a medical condition and Prevent disease.

Market Analysis and Insights: Global IVD Infectious Diseases Market
The global IVD Infectious Diseases market size is projected to reach US$ 22230 million by 2027, from US$ 16620 million in 2020, at a CAGR of 3.8% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global IVD Infectious Diseases market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global IVD Infectious Diseases market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global IVD Infectious Diseases market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global IVD Infectious Diseases market.

Global IVD Infectious Diseases Scope and Market Size
IVD Infectious Diseases market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global IVD Infectious Diseases market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Immunochemistry
Molecular Diagnostics

Segment by Application
Clinical Laboratories
Diagnostic Centers

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
BD
BioMerieux
Abbott
Quidel
Gen-Probe
Abbott
Danaher
Sysmex
Orasure
Hologic
Cepheid
Qiagen
Roche Diagnostics
Siemens Healthcare
Bio-Rad Laboratories

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global IVD Infectious Diseases Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Immunochemistry
1.2.3 Molecular Diagnostics
1.3 Market by Application
1.3.1 Global IVD Infectious Diseases Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinical Laboratories
1.3.3 Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global IVD Infectious Diseases Market Perspective (2016-2027)
2.2 IVD Infectious Diseases Growth Trends by Regions
2.2.1 IVD Infectious Diseases Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 IVD Infectious Diseases Historic Market Share by Regions (2016-2021)
2.2.3 IVD Infectious Diseases Forecasted Market Size by Regions (2022-2027)
2.3 IVD Infectious Diseases Industry Dynamic
2.3.1 IVD Infectious Diseases Market Trends
2.3.2 IVD Infectious Diseases Market Drivers
2.3.3 IVD Infectious Diseases Market Challenges
2.3.4 IVD Infectious Diseases Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top IVD Infectious Diseases Players by Revenue
3.1.1 Global Top IVD Infectious Diseases Players by Revenue (2016-2021)
3.1.2 Global IVD Infectious Diseases Revenue Market Share by Players (2016-2021)
3.2 Global IVD Infectious Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by IVD Infectious Diseases Revenue
3.4 Global IVD Infectious Diseases Market Concentration Ratio
3.4.1 Global IVD Infectious Diseases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by IVD Infectious Diseases Revenue in 2020
3.5 IVD Infectious Diseases Key Players Head office and Area Served
3.6 Key Players IVD Infectious Diseases Product Solution and Service
3.7 Date of Enter into IVD Infectious Diseases Market
3.8 Mergers & Acquisitions, Expansion Plans

4 IVD Infectious Diseases Breakdown Data by Type
4.1 Global IVD Infectious Diseases Historic Market Size by Type (2016-2021)
4.2 Global IVD Infectious Diseases Forecasted Market Size by Type (2022-2027)

5 IVD Infectious Diseases Breakdown Data by Application
5.1 Global IVD Infectious Diseases Historic Market Size by Application (2016-2021)
5.2 Global IVD Infectious Diseases Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America IVD Infectious Diseases Market Size (2016-2027)
6.2 North America IVD Infectious Diseases Market Size by Type
6.2.1 North America IVD Infectious Diseases Market Size by Type (2016-2021)
6.2.2 North America IVD Infectious Diseases Market Size by Type (2022-2027)
6.2.3 North America IVD Infectious Diseases Market Size by Type (2016-2027)
6.3 North America IVD Infectious Diseases Market Size by Application
6.3.1 North America IVD Infectious Diseases Market Size by Application (2016-2021)
6.3.2 North America IVD Infectious Diseases Market Size by Application (2022-2027)
6.3.3 North America IVD Infectious Diseases Market Size by Application (2016-2027)
6.4 North America IVD Infectious Diseases Market Size by Country
6.4.1 North America IVD Infectious Diseases Market Size by Country (2016-2021)
6.4.2 North America IVD Infectious Diseases Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe IVD Infectious Diseases Market Size (2016-2027)
7.2 Europe IVD Infectious Diseases Market Size by Type
7.2.1 Europe IVD Infectious Diseases Market Size by Type (2016-2021)
7.2.2 Europe IVD Infectious Diseases Market Size by Type (2022-2027)
7.2.3 Europe IVD Infectious Diseases Market Size by Type (2016-2027)
7.3 Europe IVD Infectious Diseases Market Size by Application
7.3.1 Europe IVD Infectious Diseases Market Size by Application (2016-2021)
7.3.2 Europe IVD Infectious Diseases Market Size by Application (2022-2027)
7.3.3 Europe IVD Infectious Diseases Market Size by Application (2016-2027)
7.4 Europe IVD Infectious Diseases Market Size by Country
7.4.1 Europe IVD Infectious Diseases Market Size by Country (2016-2021)
7.4.2 Europe IVD Infectious Diseases Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific IVD Infectious Diseases Market Size (2016-2027)
8.2 Asia-Pacific IVD Infectious Diseases Market Size by Type
8.2.1 Asia-Pacific IVD Infectious Diseases Market Size by Type (2016-2021)
8.2.2 Asia-Pacific IVD Infectious Diseases Market Size by Type (2022-2027)
8.2.3 Asia-Pacific IVD Infectious Diseases Market Size by Type (2016-2027)
8.3 Asia-Pacific IVD Infectious Diseases Market Size by Application
8.3.1 Asia-Pacific IVD Infectious Diseases Market Size by Application (2016-2021)
8.3.2 Asia-Pacific IVD Infectious Diseases Market Size by Application (2022-2027)
8.3.3 Asia-Pacific IVD Infectious Diseases Market Size by Application (2016-2027)
8.4 Asia-Pacific IVD Infectious Diseases Market Size by Region
8.4.1 Asia-Pacific IVD Infectious Diseases Market Size by Region (2016-2021)
8.4.2 Asia-Pacific IVD Infectious Diseases Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America IVD Infectious Diseases Market Size (2016-2027)
9.2 Latin America IVD Infectious Diseases Market Size by Type
9.2.1 Latin America IVD Infectious Diseases Market Size by Type (2016-2021)
9.2.2 Latin America IVD Infectious Diseases Market Size by Type (2022-2027)
9.2.3 Latin America IVD Infectious Diseases Market Size by Type (2016-2027)
9.3 Latin America IVD Infectious Diseases Market Size by Application
9.3.1 Latin America IVD Infectious Diseases Market Size by Application (2016-2021)
9.3.2 Latin America IVD Infectious Diseases Market Size by Application (2022-2027)
9.3.3 Latin America IVD Infectious Diseases Market Size by Application (2016-2027)
9.4 Latin America IVD Infectious Diseases Market Size by Country
9.4.1 Latin America IVD Infectious Diseases Market Size by Country (2016-2021)
9.4.2 Latin America IVD Infectious Diseases Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa IVD Infectious Diseases Market Size (2016-2027)
10.2 Middle East & Africa IVD Infectious Diseases Market Size by Type
10.2.1 Middle East & Africa IVD Infectious Diseases Market Size by Type (2016-2021)
10.2.2 Middle East & Africa IVD Infectious Diseases Market Size by Type (2022-2027)
10.2.3 Middle East & Africa IVD Infectious Diseases Market Size by Type (2016-2027)
10.3 Middle East & Africa IVD Infectious Diseases Market Size by Application
10.3.1 Middle East & Africa IVD Infectious Diseases Market Size by Application (2016-2021)
10.3.2 Middle East & Africa IVD Infectious Diseases Market Size by Application (2022-2027)
10.3.3 Middle East & Africa IVD Infectious Diseases Market Size by Application (2016-2027)
10.4 Middle East & Africa IVD Infectious Diseases Market Size by Country
10.4.1 Middle East & Africa IVD Infectious Diseases Market Size by Country (2016-2021)
10.4.2 Middle East & Africa IVD Infectious Diseases Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 BD
11.1.1 BD Company Details
11.1.2 BD Business Overview
11.1.3 BD IVD Infectious Diseases Introduction
11.1.4 BD Revenue in IVD Infectious Diseases Business (2016-2021)
11.1.5 BD Recent Development
11.2 BioMerieux
11.2.1 BioMerieux Company Details
11.2.2 BioMerieux Business Overview
11.2.3 BioMerieux IVD Infectious Diseases Introduction
11.2.4 BioMerieux Revenue in IVD Infectious Diseases Business (2016-2021)
11.2.5 BioMerieux Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott IVD Infectious Diseases Introduction
11.3.4 Abbott Revenue in IVD Infectious Diseases Business (2016-2021)
11.3.5 Abbott Recent Development
11.4 Quidel
11.4.1 Quidel Company Details
11.4.2 Quidel Business Overview
11.4.3 Quidel IVD Infectious Diseases Introduction
11.4.4 Quidel Revenue in IVD Infectious Diseases Business (2016-2021)
11.4.5 Quidel Recent Development
11.5 Gen-Probe
11.5.1 Gen-Probe Company Details
11.5.2 Gen-Probe Business Overview
11.5.3 Gen-Probe IVD Infectious Diseases Introduction
11.5.4 Gen-Probe Revenue in IVD Infectious Diseases Business (2016-2021)
11.5.5 Gen-Probe Recent Development
11.6 Abbott
11.6.1 Abbott Company Details
11.6.2 Abbott Business Overview
11.6.3 Abbott IVD Infectious Diseases Introduction
11.6.4 Abbott Revenue in IVD Infectious Diseases Business (2016-2021)
11.6.5 Abbott Recent Development
11.7 Danaher
11.7.1 Danaher Company Details
11.7.2 Danaher Business Overview
11.7.3 Danaher IVD Infectious Diseases Introduction
11.7.4 Danaher Revenue in IVD Infectious Diseases Business (2016-2021)
11.7.5 Danaher Recent Development
11.8 Sysmex
11.8.1 Sysmex Company Details
11.8.2 Sysmex Business Overview
11.8.3 Sysmex IVD Infectious Diseases Introduction
11.8.4 Sysmex Revenue in IVD Infectious Diseases Business (2016-2021)
11.8.5 Sysmex Recent Development
11.9 Orasure
11.9.1 Orasure Company Details
11.9.2 Orasure Business Overview
11.9.3 Orasure IVD Infectious Diseases Introduction
11.9.4 Orasure Revenue in IVD Infectious Diseases Business (2016-2021)
11.9.5 Orasure Recent Development
11.10 Hologic
11.10.1 Hologic Company Details
11.10.2 Hologic Business Overview
11.10.3 Hologic IVD Infectious Diseases Introduction
11.10.4 Hologic Revenue in IVD Infectious Diseases Business (2016-2021)
11.10.5 Hologic Recent Development
11.11 Cepheid
11.11.1 Cepheid Company Details
11.11.2 Cepheid Business Overview
11.11.3 Cepheid IVD Infectious Diseases Introduction
11.11.4 Cepheid Revenue in IVD Infectious Diseases Business (2016-2021)
11.11.5 Cepheid Recent Development
11.12 Qiagen
11.12.1 Qiagen Company Details
11.12.2 Qiagen Business Overview
11.12.3 Qiagen IVD Infectious Diseases Introduction
11.12.4 Qiagen Revenue in IVD Infectious Diseases Business (2016-2021)
11.12.5 Qiagen Recent Development
11.13 Roche Diagnostics
11.13.1 Roche Diagnostics Company Details
11.13.2 Roche Diagnostics Business Overview
11.13.3 Roche Diagnostics IVD Infectious Diseases Introduction
11.13.4 Roche Diagnostics Revenue in IVD Infectious Diseases Business (2016-2021)
11.13.5 Roche Diagnostics Recent Development
11.14 Siemens Healthcare
11.14.1 Siemens Healthcare Company Details
11.14.2 Siemens Healthcare Business Overview
11.14.3 Siemens Healthcare IVD Infectious Diseases Introduction
11.14.4 Siemens Healthcare Revenue in IVD Infectious Diseases Business (2016-2021)
11.14.5 Siemens Healthcare Recent Development
11.15 Bio-Rad Laboratories
11.15.1 Bio-Rad Laboratories Company Details
11.15.2 Bio-Rad Laboratories Business Overview
11.15.3 Bio-Rad Laboratories IVD Infectious Diseases Introduction
11.15.4 Bio-Rad Laboratories Revenue in IVD Infectious Diseases Business (2016-2021)
11.15.5 Bio-Rad Laboratories Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global IVD Infectious Diseases Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Immunochemistry
Table 3. Key Players of Molecular Diagnostics
Table 4. Global IVD Infectious Diseases Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global IVD Infectious Diseases Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global IVD Infectious Diseases Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global IVD Infectious Diseases Market Share by Regions (2016-2021)
Table 8. Global IVD Infectious Diseases Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global IVD Infectious Diseases Market Share by Regions (2022-2027)
Table 10. IVD Infectious Diseases Market Trends
Table 11. IVD Infectious Diseases Market Drivers
Table 12. IVD Infectious Diseases Market Challenges
Table 13. IVD Infectious Diseases Market Restraints
Table 14. Global IVD Infectious Diseases Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global IVD Infectious Diseases Market Share by Players (2016-2021)
Table 16. Global Top IVD Infectious Diseases Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IVD Infectious Diseases as of 2020)
Table 17. Ranking of Global Top IVD Infectious Diseases Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by IVD Infectious Diseases Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players IVD Infectious Diseases Product Solution and Service
Table 21. Date of Enter into IVD Infectious Diseases Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global IVD Infectious Diseases Market Size by Type (2016-2021) (US$ Million)
Table 24. Global IVD Infectious Diseases Revenue Market Share by Type (2016-2021)
Table 25. Global IVD Infectious Diseases Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global IVD Infectious Diseases Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global IVD Infectious Diseases Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global IVD Infectious Diseases Revenue Market Share by Application (2016-2021)
Table 29. Global IVD Infectious Diseases Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global IVD Infectious Diseases Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America IVD Infectious Diseases Market Size by Type (2016-2021) (US$ Million)
Table 32. North America IVD Infectious Diseases Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America IVD Infectious Diseases Market Size by Application (2016-2021) (US$ Million)
Table 34. North America IVD Infectious Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America IVD Infectious Diseases Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America IVD Infectious Diseases Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe IVD Infectious Diseases Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe IVD Infectious Diseases Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe IVD Infectious Diseases Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe IVD Infectious Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe IVD Infectious Diseases Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe IVD Infectious Diseases Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific IVD Infectious Diseases Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific IVD Infectious Diseases Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific IVD Infectious Diseases Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific IVD Infectious Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific IVD Infectious Diseases Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific IVD Infectious Diseases Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America IVD Infectious Diseases Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America IVD Infectious Diseases Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America IVD Infectious Diseases Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America IVD Infectious Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America IVD Infectious Diseases Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America IVD Infectious Diseases Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa IVD Infectious Diseases Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa IVD Infectious Diseases Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa IVD Infectious Diseases Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa IVD Infectious Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa IVD Infectious Diseases Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa IVD Infectious Diseases Market Size by Country (2022-2027) & (US$ Million)
Table 61. BD Company Details
Table 62. BD Business Overview
Table 63. BD IVD Infectious Diseases Product
Table 64. BD Revenue in IVD Infectious Diseases Business (2016-2021) & (US$ Million)
Table 65. BD Recent Development
Table 66. BioMerieux Company Details
Table 67. BioMerieux Business Overview
Table 68. BioMerieux IVD Infectious Diseases Product
Table 69. BioMerieux Revenue in IVD Infectious Diseases Business (2016-2021) & (US$ Million)
Table 70. BioMerieux Recent Development
Table 71. Abbott Company Details
Table 72. Abbott Business Overview
Table 73. Abbott IVD Infectious Diseases Product
Table 74. Abbott Revenue in IVD Infectious Diseases Business (2016-2021) & (US$ Million)
Table 75. Abbott Recent Development
Table 76. Quidel Company Details
Table 77. Quidel Business Overview
Table 78. Quidel IVD Infectious Diseases Product
Table 79. Quidel Revenue in IVD Infectious Diseases Business (2016-2021) & (US$ Million)
Table 80. Quidel Recent Development
Table 81. Gen-Probe Company Details
Table 82. Gen-Probe Business Overview
Table 83. Gen-Probe IVD Infectious Diseases Product
Table 84. Gen-Probe Revenue in IVD Infectious Diseases Business (2016-2021) & (US$ Million)
Table 85. Gen-Probe Recent Development
Table 86. Abbott Company Details
Table 87. Abbott Business Overview
Table 88. Abbott IVD Infectious Diseases Product
Table 89. Abbott Revenue in IVD Infectious Diseases Business (2016-2021) & (US$ Million)
Table 90. Abbott Recent Development
Table 91. Danaher Company Details
Table 92. Danaher Business Overview
Table 93. Danaher IVD Infectious Diseases Product
Table 94. Danaher Revenue in IVD Infectious Diseases Business (2016-2021) & (US$ Million)
Table 95. Danaher Recent Development
Table 96. Sysmex Company Details
Table 97. Sysmex Business Overview
Table 98. Sysmex Revenue in IVD Infectious Diseases Business (2016-2021) & (US$ Million)
Table 99. Sysmex Recent Development
Table 100. Orasure Company Details
Table 101. Orasure Business Overview
Table 102. Orasure IVD Infectious Diseases Product
Table 103. Orasure Revenue in IVD Infectious Diseases Business (2016-2021) & (US$ Million)
Table 104. Orasure Recent Development
Table 105. Hologic Company Details
Table 106. Hologic Business Overview
Table 107. Hologic IVD Infectious Diseases Product
Table 108. Hologic Revenue in IVD Infectious Diseases Business (2016-2021) & (US$ Million)
Table 109. Hologic Recent Development
Table 110. Cepheid Company Details
Table 111. Cepheid Business Overview
Table 112. Cepheid IVD Infectious Diseases Product
Table 113. Cepheid Revenue in IVD Infectious Diseases Business (2016-2021) & (US$ Million)
Table 114. Cepheid Recent Development
Table 115. Qiagen Company Details
Table 116. Qiagen Business Overview
Table 117. Qiagen IVD Infectious Diseases Product
Table 118. Qiagen Revenue in IVD Infectious Diseases Business (2016-2021) & (US$ Million)
Table 119. Qiagen Recent Development
Table 120. Roche Diagnostics Company Details
Table 121. Roche Diagnostics Business Overview
Table 122. Roche Diagnostics IVD Infectious Diseases Product
Table 123. Roche Diagnostics Revenue in IVD Infectious Diseases Business (2016-2021) & (US$ Million)
Table 124. Roche Diagnostics Recent Development
Table 125. Siemens Healthcare Company Details
Table 126. Siemens Healthcare Business Overview
Table 127. Siemens Healthcare IVD Infectious Diseases Product
Table 128. Siemens Healthcare Revenue in IVD Infectious Diseases Business (2016-2021) & (US$ Million)
Table 129. Siemens Healthcare Recent Development
Table 130. Bio-Rad Laboratories Company Details
Table 131. Bio-Rad Laboratories Business Overview
Table 132. Bio-Rad Laboratories IVD Infectious Diseases Product
Table 133. Bio-Rad Laboratories Revenue in IVD Infectious Diseases Business (2016-2021) & (US$ Million)
Table 134. Bio-Rad Laboratories Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global IVD Infectious Diseases Market Share by Type: 2020 VS 2027
Figure 2. Immunochemistry Features
Figure 3. Molecular Diagnostics Features
Figure 4. Global IVD Infectious Diseases Market Share by Application: 2020 VS 2027
Figure 5. Clinical Laboratories Case Studies
Figure 6. Diagnostic Centers Case Studies
Figure 7. IVD Infectious Diseases Report Years Considered
Figure 8. Global IVD Infectious Diseases Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global IVD Infectious Diseases Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global IVD Infectious Diseases Market Share by Regions: 2020 VS 2027
Figure 11. Global IVD Infectious Diseases Market Share by Regions (2022-2027)
Figure 12. Global IVD Infectious Diseases Market Share by Players in 2020
Figure 13. Global Top IVD Infectious Diseases Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IVD Infectious Diseases as of 2020
Figure 14. The Top 10 and 5 Players Market Share by IVD Infectious Diseases Revenue in 2020
Figure 15. Global IVD Infectious Diseases Revenue Market Share by Type (2016-2021)
Figure 16. Global IVD Infectious Diseases Revenue Market Share by Type (2022-2027)
Figure 17. North America IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America IVD Infectious Diseases Market Share by Type (2016-2027)
Figure 19. North America IVD Infectious Diseases Market Share by Application (2016-2027)
Figure 20. North America IVD Infectious Diseases Market Share by Country (2016-2027)
Figure 21. United States IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe IVD Infectious Diseases Market Share by Type (2016-2027)
Figure 25. Europe IVD Infectious Diseases Market Share by Application (2016-2027)
Figure 26. Europe IVD Infectious Diseases Market Share by Country (2016-2027)
Figure 27. Germany IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific IVD Infectious Diseases Market Share by Type (2016-2027)
Figure 35. Asia-Pacific IVD Infectious Diseases Market Share by Application (2016-2027)
Figure 36. Asia-Pacific IVD Infectious Diseases Market Share by Region (2016-2027)
Figure 37. China IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America IVD Infectious Diseases Market Share by Type (2016-2027)
Figure 45. Latin America IVD Infectious Diseases Market Share by Application (2016-2027)
Figure 46. Latin America IVD Infectious Diseases Market Share by Country (2016-2027)
Figure 47. Mexico IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa IVD Infectious Diseases Market Share by Type (2016-2027)
Figure 51. Middle East & Africa IVD Infectious Diseases Market Share by Application (2016-2027)
Figure 52. Middle East & Africa IVD Infectious Diseases Market Share by Country (2016-2027)
Figure 53. Turkey IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. BD Revenue Growth Rate in IVD Infectious Diseases Business (2016-2021)
Figure 57. BioMerieux Revenue Growth Rate in IVD Infectious Diseases Business (2016-2021)
Figure 58. Abbott Revenue Growth Rate in IVD Infectious Diseases Business (2016-2021)
Figure 59. Quidel Revenue Growth Rate in IVD Infectious Diseases Business (2016-2021)
Figure 60. Gen-Probe Revenue Growth Rate in IVD Infectious Diseases Business (2016-2021)
Figure 61. Abbott Revenue Growth Rate in IVD Infectious Diseases Business (2016-2021)
Figure 62. Danaher Revenue Growth Rate in IVD Infectious Diseases Business (2016-2021)
Figure 63. Sysmex Revenue Growth Rate in IVD Infectious Diseases Business (2016-2021)
Figure 64. Orasure Revenue Growth Rate in IVD Infectious Diseases Business (2016-2021)
Figure 65. Hologic Revenue Growth Rate in IVD Infectious Diseases Business (2016-2021)
Figure 66. Cepheid Revenue Growth Rate in IVD Infectious Diseases Business (2016-2021)
Figure 67. Qiagen Revenue Growth Rate in IVD Infectious Diseases Business (2016-2021)
Figure 68. Roche Diagnostics Revenue Growth Rate in IVD Infectious Diseases Business (2016-2021)
Figure 69. Siemens Healthcare Revenue Growth Rate in IVD Infectious Diseases Business (2016-2021)
Figure 70. Bio-Rad Laboratories Revenue Growth Rate in IVD Infectious Diseases Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

以下、関連資料のご紹介

世界の感染症用体外診断薬市場規模・現状・予測（2021年-2027年）

Global Infectious Diseases In Vitro Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4363 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、感染症用体外診断薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（MRSA、連鎖球菌、結核＆薬剤耐性結核、消化器パネル検査、HIV、C型肝炎、その他）、用途別市場規模（免疫化学、分子診断、微生物学、そ...

世界の感染症治療薬市場規模・現状・予測（2021年-2027年）

Global Infectious Disease Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5800 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、感染症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗菌剤、抗ウイルス剤、抗寄生虫剤、抗真菌剤、その他）、用途別市場規模（HIV、マラリア、肝炎、インフルエンザ、HPV、結核、その他）、主要地...

世界の寄生虫病治療市場規模・現状・予測（2021年-2027年）

Global Parasitic Diseases Therapeutic Market Size, Status and Forecast 2021-2027
QFJ1-5930 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、寄生虫病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ペプチド薬、防虫剤、殺ダニ剤、その他）、用途別市場規模（商業用、家庭用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界の非感染性黄斑浮腫治療市場規模・現状・予測（2021年-2027年）

Global Non-infectious Macular Edema Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5891 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、非感染性黄斑浮腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗VEGF療法、コルチコステロイド、免疫阻害剤、生物学的製剤、その他）、用途別市場規模（小売薬局、病院薬局、その他）、主要地域別市場...

世界の感染症診断市場規模・現状・予測（2021年-2027年）

Global Infectious Disease Diagnosis Market Size, Status and Forecast 2021-2027
QFJ1-4361 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、感染症診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（尿、血液、その他）、用途別市場規模（病院＆外傷センター、診断研究所、リハビリテーションセンター）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の医療関連感染症診断市場規模・現状・予測（2021年-2027年）

Global Healthcare-associated Infectious Disease Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4288 2021年6月 123Pages
QYResearch社発行の本調査レポートでは、医療関連感染症診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（尿路感染症、手術部位感染症、院内肺炎、菌血症、胃腸感染症）、用途別市場規模（病院、診療所、ASC）、主要地域別市場規模（北米、アメリカ...

世界の子宮疾患治療薬市場規模・現状・予測（2021年-2027年）

Global Uterine Diseases Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5004 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、子宮疾患治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、外科治療）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界のポイントオブケア感染症市場規模・現状・予測（2021年-2027年）

Global Point of Care Infectious Disease Market Size, Status and Forecast 2021-2027
QFJ1-4724 2021年6月 119Pages
QYResearch社発行の本調査レポートでは、ポイントオブケア感染症の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（HIV POC、クロストリジウムディフィシルPOC、HBV POC、肺炎/連鎖球菌関連感染症、呼吸器合胞体ウイルス（RSV）POC...

世界のアルコール性肝疾患治療市場規模・現状・予測（2021年-2027年）

Global Alcoholic Liver Diseases Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5570 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、アルコール性肝疾患治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アルコール性脂肪肝疾患、アルコール性肝肝炎、その他）、用途別市場規模（病院薬局、小売薬局、ドラッグストア、オンライン薬局、その他）...

世界のゴーシェ病＆ポンペ病酵素補充療法市場規模・現状・予測（2021年-2027年）

Global Gaucher and Pompe Diseases Enzyme Replacement Therapy Market Size, Status and Forecast 2021-2027
QFJ1-5746 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、ゴーシェ病＆ポンペ病酵素補充療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、非経口）、用途別市場規模（病院薬局、小売薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中...

世界の感染症用体外診断薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Infectious Diseases In Vitro Diagnostics Market The global Infectious Diseases In Vitro Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analys…
感染症診断のグローバル市場：規模・現状・予測2019-2025 Infectious Diseases Diagnostic is used for confirmation of a disease that can be spreaded in form of a quick, precise test result.In 2018, the global Infectious Diseases Diagnostic market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during…
感染症診断のグローバル市場：規模・現状・予測2019-2025 Infectious Diseases Diagnostic is used for confirmation of a disease that can be spreaded in form of a quick, precise test result.In 2018, the global Infectious Diseases Diagnostic market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during…
感染症診断のグローバル市場：規模・現状・予測2019-2025 Infectious Diseases Diagnostic is used for confirmation of a disease that can be spreaded in form of a quick, precise test result.In 2018, the global Infectious Diseases Diagnostic market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during…
世界の感染症診断市場規模・現状・予測（2021年-2027年） Infectious Diseases Diagnosis is used for confirmation of a disease that can be spreaded in form of a quick, precise test result. Market Analysis and Insights: Global Infectious Disease Diagnosis Market The global Infectious Disease Diagnosis market size is projected to reach US$ XX million by 2027,…